Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles
- PMID: 31228418
- DOI: 10.1016/j.exppara.2019.107717
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles
Abstract
Spiramycin-metronidazole and spiramycin-loaded chitosan (CS) nanoparticles (NPs) were tested in comparison with the current spiramycin treatment of T.gondii concerning tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain and were divided into experimental and control groups. The experimental groups orally received CS NPs, spiramycin, spiramycin-metronidazole, spiramycin-loaded CS NPs 400 mg/kg and spiramycin-loaded CS NPs 100 mg/kg. Drug efficacy was assessed by mice survival time, mortality rate, parasite load in different organs and morphological study of the tachyzoites movement by light microscope and the ultra-structure by SEM. The results revealed that the maximum survival time of more than 200 days with no mortality on the sacrifice day (8th) was observed in mice receiving spiramycin-loaded NPs. Spiramycin-loaded NPs showed the highest significant percent reduction of tachyzoites (about 90% reduction) in liver, spleen and brain as compared to the other used drugs denoting successful bypass of BBB. Light microscopy of the treated peritoneal tachyzoites showed sluggish tachyzoites movement while the NPs caused loss of their movement. SEM of the treated tachyzoites were more mutilated and some of them appeared rupturing in those receiving CS NPs and spiramycin-loaded NPs. In conclusion, spiramycin-loaded NPs showed the highest efficiency in the treatment of acute toxoplasmosis. The non-toxic nature and the anti-parasitic effect of both CS and spiramycin make the use of spiramycin-loaded CS NPs a potential material for treatment of human toxoplasmosis.
Keywords: CS NPs; Spiramycin; Spiramycin-loaded NPs; Spiramycin-metronidazole; Toxoplasma gondii.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.PLoS Negl Trop Dis. 2022 Mar 16;16(3):e0010268. doi: 10.1371/journal.pntd.0010268. eCollection 2022 Mar. PLoS Negl Trop Dis. 2022. PMID: 35294434 Free PMC article.
-
Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.J Parasit Dis. 2022 Mar;46(1):166-177. doi: 10.1007/s12639-021-01431-9. Epub 2021 Aug 10. J Parasit Dis. 2022. PMID: 35299902 Free PMC article.
-
Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.Exp Parasitol. 2015 Feb;149:54-64. doi: 10.1016/j.exppara.2014.12.007. Epub 2014 Dec 9. Exp Parasitol. 2015. PMID: 25499511
-
Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain.Int J Nanomedicine. 2018 Mar 8;13:1341-1351. doi: 10.2147/IJN.S158736. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29563791 Free PMC article.
-
A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies.Eur J Med Res. 2021 Dec 11;26(1):143. doi: 10.1186/s40001-021-00606-7. Eur J Med Res. 2021. PMID: 34895348 Free PMC article. Review.
Cited by
-
Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.PLoS Negl Trop Dis. 2023 Jul 6;17(7):e0011447. doi: 10.1371/journal.pntd.0011447. eCollection 2023 Jul. PLoS Negl Trop Dis. 2023. PMID: 37410712 Free PMC article.
-
Formulation and evaluation of atovaquone-loaded macrophage-derived exosomes against Toxoplasma gondii: in vitro and in vivo assessment.Microbiol Spectr. 2024 Jan 11;12(1):e0308023. doi: 10.1128/spectrum.03080-23. Epub 2023 Nov 28. Microbiol Spectr. 2024. PMID: 38014940 Free PMC article.
-
Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents.Int J Mol Sci. 2022 Apr 11;23(8):4241. doi: 10.3390/ijms23084241. Int J Mol Sci. 2022. PMID: 35457059 Free PMC article.
-
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.PLoS Negl Trop Dis. 2022 Mar 16;16(3):e0010268. doi: 10.1371/journal.pntd.0010268. eCollection 2022 Mar. PLoS Negl Trop Dis. 2022. PMID: 35294434 Free PMC article.
-
Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.World J Microbiol Biotechnol. 2021 Feb 10;37(3):48. doi: 10.1007/s11274-021-03000-x. World J Microbiol Biotechnol. 2021. PMID: 33566198 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources